These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24916368)

  • 81. Combination renin-angiotensin system blockade in hypertension.
    Doulton TW; Macgregor GA
    Kidney Int; 2005 Oct; 68(4):1898. PubMed ID: 16164672
    [No Abstract]   [Full Text] [Related]  

  • 82. Preventing renal disease progression: can complete renin-angiotensin-aldosterone blockade work?
    Schreiber MJ
    Cleve Clin J Med; 2008 Oct; 75(10):699-700, 703-4. PubMed ID: 18939385
    [No Abstract]   [Full Text] [Related]  

  • 83. Use of renin-angiotensin system blockade in patients with renal artery stenosis.
    Cohen JB; Townsend RR
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1149-52. PubMed ID: 24903389
    [No Abstract]   [Full Text] [Related]  

  • 84. Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis.
    Zaffanello M
    Pediatr Nephrol; 2009 Jan; 24(1):217-8. PubMed ID: 18688656
    [No Abstract]   [Full Text] [Related]  

  • 85. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J
    Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract]   [Full Text] [Related]  

  • 86. Renin inhibition: the next step in suppression of the renin-angiotensin system?
    Azizi M
    Curr Hypertens Rep; 2007 Apr; 9(2):81-3. PubMed ID: 17442216
    [No Abstract]   [Full Text] [Related]  

  • 87. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Can drugs influencing the renin-angiotensin system prevent diabetes mellitus? A lesson from randomized clinical trials.
    Filipiak KJ
    Cardiol J; 2010; 17(5):435-6. PubMed ID: 20865671
    [No Abstract]   [Full Text] [Related]  

  • 89. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 90. Interference with the renin-angiotensin system in heart failure.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):331-4. PubMed ID: 16468022
    [No Abstract]   [Full Text] [Related]  

  • 91. ACE inhibitors and angiotensin II receptor antagonists in Crohn's disease management.
    Hume GE; Radford-Smith GL
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):645-51. PubMed ID: 19072342
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.
    Jandeleit-Dahm KA; Tikellis C; Reid CM; Johnston CI; Cooper ME
    J Hypertens; 2005 Mar; 23(3):463-73. PubMed ID: 15716683
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA; Giles TD
    Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.
    Gales BJ; Bailey EK; Reed AN; Gales MA
    Ann Pharmacother; 2010 Feb; 44(2):360-6. PubMed ID: 20086184
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.
    Salata K; Syed M; Hussain MA; Eikelboom R; de Mestral C; Verma S; Al-Omran M
    J Vasc Surg; 2018 Feb; 67(2):629-636.e2. PubMed ID: 29175038
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Use of Angiotensin Receptor Blockers and Risk of Alzheimer's Disease: A Class Effect?
    Mangoni AA; Jarmuzewska EA
    Curr Rev Clin Exp Pharmacol; 2021; 16(1):2-3. PubMed ID: 34528501
    [No Abstract]   [Full Text] [Related]  

  • 97. Report on Second International Conference on Natural Products for Cancer Prevention and Therapy Held in Kayseri, Turkey, 8-11 November 2017.
    Yerer MB; Bishayee A
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295493
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects.
    Ouyang X; Xu C
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2595-2605. PubMed ID: 36153775
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
    Battistoni A; Volpe M
    Eur Cardiol; 2020 Feb; 15():e21. PubMed ID: 32419852
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Are the antagonists of the renin-angiotensin system also anticancer agents?
    Lonati C; Morganti A
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):99-102. PubMed ID: 24916368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.